Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,041 DKK | +0.74% | +1.90% | -5.29% |
05-15 | Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation' | MT |
05-15 | Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.29% | 19.07B | |
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B | |
-24.95% | 8.45B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Genmab: A good start to 2024; guidance unchanged